|
|
|
|
|
|
|
Ark Genomic Revolution Multi-Sector ETF (ARKG)
|
|
27.86 -0.27 (-0.96%)
|
05-21 16:00
|
|
Open:
|
28.26
|
Pre. Close:
|
28.13
|
|
High:
|
28.4
|
Low:
|
27.7
|
|
Volume:
|
46,094
|
Market Cap:
|
0M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
28.421 - 28.555
|
28.555 - 28.682
|
|
Low:
|
27.354 - 27.509
|
27.509 - 27.656
|
|
Close:
|
27.975 - 28.219
|
28.219 - 28.448
|
|
|
|
Technical analysis (as of: 2018-05-21 4:26:52 PM)
|
|
Overall:
|
 
|
|
Stoxline posted a NEUTRAL today, upgraded from lower rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.
|
|
Target:
|
Six months: 33.43 One year: 39.04
|
|
Support:
|
Support1: 26.45 Support2: 25.11
|
|
Resistance:
|
Resistance1:
28.62 Resistance2: 33.43
|
|
Pivot:
|
27.08
|
|
Moving Averages:
|
MA(5): 28.23 MA(20): 26.74
MA(100): 26.78 MA(250): 25.05
|
|
MACD:
|
MACD(12,26):
0.52 Signal(12,26,9): 0.29
|
|
%K %D:
|
%K(14,3): 91.35  %D(3): 92.52
|
|
RSI:
|
RSI(14): 63.76
|
|
52-Week:
|
High: 30.51
Low: 19.973 Change(%): 35.7
|
|
Average Vol(K):
|
3-Month: 10072
10-Days 8498
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.ARKG has closed below upper band by 23.3%. Bollinger Bands are 26.9% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
2018-04-04T07:59:46-04:00
Healthcare sector in the red premarket on Trump/Xi tariff tit-for-tat
2018-03-15T15:59:47-04:00
Billions on the line as White House and insurers wait for appeals court decision on ACA payments
2018-02-20T10:22:33-05:00
Compugen Ltd.: An Undervalued Disruptive Innovation Company
2018-02-05T06:57:34-05:00
Will healthcare stocks hold steady amidst broad selloff?
2018-01-16T11:07:19-05:00
FDA launches accelerated review program for products needed by DoD
2018-01-12T20:58:44-05:00
Separating Winners From Losers In A Volatile Healthcare Environment
2018-01-08T11:56:31-05:00
Start of JPM18 fails to buoy healthcare stocks
2017-12-15T14:47:17-05:00
Chirality, From Chemical Supply Houses To Life As We Know It
|
|
|
Financial Analysis
|
|
Growth
|
NA
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
NA
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
NA
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
NA
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
